244 related articles for article (PubMed ID: 12869227)
1. Management of HIV and hepatitis B or C co-infection in 15 HIV treatment centres. Disparity between protocols and practice.
Brook MG; Jones K; Dale AW; Miller RF
Int J STD AIDS; 2003 Jul; 14(7):469-72. PubMed ID: 12869227
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.
Gaglio PJ; Sterling R; Daniels E; Tedaldi E;
Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998
[TBL] [Abstract][Full Text] [Related]
3. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
4. Summary of BHIVA guidelines for HIV and hepatitis B or C co-infection.
Brook MG
J HIV Ther; 2003 Nov; 8(4):85-8. PubMed ID: 14671505
[TBL] [Abstract][Full Text] [Related]
5. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection.
Dervisevic S; Pillay D
J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
[TBL] [Abstract][Full Text] [Related]
7. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
[TBL] [Abstract][Full Text] [Related]
8. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa.
Cooper CL; Mills E; Wabwire BO; Ford N; Olupot-Olupot P
Int J Infect Dis; 2009 May; 13(3):302-6. PubMed ID: 19004656
[TBL] [Abstract][Full Text] [Related]
9. [Chronic hepatitis B and C in HIV-infected patients].
Opravil M; Hunziker R; Lüthy R; Grob PJ
Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
[TBL] [Abstract][Full Text] [Related]
10. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
[TBL] [Abstract][Full Text] [Related]
11. Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
Clotet B; Clumeck N; Katlama C; Nijs S; Witek J
J Antimicrob Chemother; 2010 Nov; 65(11):2450-4. PubMed ID: 20801782
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy.
Calisti G; Muhindo R; Boum Y; Wilson LA; Foster GM; Geretti AM; Bhagani S
Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):723-9. PubMed ID: 26386408
[TBL] [Abstract][Full Text] [Related]
13. Need for improvements in the surveillance and management of chronic viral hepatitis in HIV patients followed in a Danish outpatient clinic.
Andersen KL; Larsen CS; Petersen MS; Leutscher PD
Scand J Infect Dis; 2014 Aug; 46(8):578-84. PubMed ID: 24934989
[TBL] [Abstract][Full Text] [Related]
14. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells].
Smit MC; Haverkamp MH; Weersink AJ; Boucher CA; Hoepelman IM
Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2330-4. PubMed ID: 15587052
[TBL] [Abstract][Full Text] [Related]
15. Management and treatment of chronic hepatitis B in HIV-positive patients.
Soriano V; de Mendoza C; Fernández-Montero JV; Labarga P; Barreiro P
Ann Med; 2014 Aug; 46(5):290-6. PubMed ID: 24716736
[TBL] [Abstract][Full Text] [Related]
16. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study.
Zhang F; Zhu H; Wu Y; Dou Z; Zhang Y; Kleinman N; Bulterys M; Wu Z; Ma Y; Zhao D; Liu X; Fang H; Liu J; Cai WP; Shang H
Lancet Infect Dis; 2014 Nov; 14(11):1065-1072. PubMed ID: 25303841
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
Goedert JJ;
Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
Maier KP
Praxis (Bern 1994); 2003 Aug; 92(33):1351-7. PubMed ID: 14502791
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and human immunodeficiency virus co-infection.
Phung BC; Sogni P; Launay O
World J Gastroenterol; 2014 Dec; 20(46):17360-7. PubMed ID: 25516647
[TBL] [Abstract][Full Text] [Related]
20. Survey of HIV and hepatitis B or C co-infection management in the UK 2004.
de Silva S; Brook MG; Curtis H; Johnson M;
Int J STD AIDS; 2006 Dec; 17(12):799-801. PubMed ID: 17212853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
